HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tine Kold Olesen Selected Research

acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide

7/2012The effect of baseline testosterone on the efficacy of degarelix and leuprolide: further insights from a 12-month, comparative, phase III study in prostate cancer patients.
9/2011A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancer.
12/2010Cardiovascular safety of degarelix: results from a 12-month, comparative, randomized, open label, parallel group phase III trial in patients with prostate cancer.
7/2010Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study.
12/2008The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer.
11/2008A 1-year, open label, randomized phase II dose finding study of degarelix for the treatment of prostate cancer in North America.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tine Kold Olesen Research Topics

Disease

7Prostatic Neoplasms (Prostate Cancer)
11/2012 - 11/2008
1Nocturia
08/2019
1Neoplasms (Cancer)
07/2012
1Hypogonadism (Hypergonadotropic Hypogonadism)
12/2010
1Myocardial Ischemia (Ischemic Heart Diseases)
12/2010
1Heart Diseases (Heart Disease)
12/2010
1Neoplasm Metastasis (Metastasis)
07/2010
1Urinary Tract Infections (Urinary Tract Infection)
12/2008
1Injection Site Reaction
12/2008
1Adenocarcinoma
12/2008

Drug/Important Bio-Agent (IBA)

6acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamideFDA Link
07/2012 - 11/2008
5Leuprolide (Lupron)FDA LinkGeneric
07/2012 - 12/2008
4Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/2012 - 12/2008
4Prostate-Specific Antigen (Semenogelase)IBA
11/2012 - 11/2008
3Hormones (Hormone)IBA
07/2012 - 12/2008
3Testosterone (Sustanon)FDA Link
07/2012 - 11/2008
1Kallikreins (Kallikrein)IBA
11/2012
1Peptide Hydrolases (Proteases)FDA Link
11/2012
1Androgen Antagonists (Antiandrogens)IBA
07/2012
1Pharmaceutical PreparationsIBA
12/2010
1Alkaline PhosphataseIBA
07/2010
1AndrogensIBA
12/2008
1GonadotropinsIBA
11/2008
1LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
11/2008

Therapy/Procedure

2Therapeutics
07/2010 - 12/2008
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
08/2019
1Injections
11/2008